Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 3
2007 1
2008 1
2011 3
2012 5
2013 1
2014 3
2015 1
2016 2
2017 3
2018 6
2019 9
2020 14
2021 11
2022 5
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments.
Stirnemann J, Belmatoug N, Camou F, Serratrice C, Froissart R, Caillaud C, Levade T, Astudillo L, Serratrice J, Brassier A, Rose C, Billette de Villemeur T, Berger MG. Stirnemann J, et al. Among authors: camou f. Int J Mol Sci. 2017 Feb 17;18(2):441. doi: 10.3390/ijms18020441. Int J Mol Sci. 2017. PMID: 28218669 Free PMC article. Review.
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection.
Wilcox MH, Gerding DN, Poxton IR, Kelly C, Nathan R, Birch T, Cornely OA, Rahav G, Bouza E, Lee C, Jenkin G, Jensen W, Kim YS, Yoshida J, Gabryelski L, Pedley A, Eves K, Tipping R, Guris D, Kartsonis N, Dorr MB; MODIFY I and MODIFY II Investigators. Wilcox MH, et al. N Engl J Med. 2017 Jan 26;376(4):305-317. doi: 10.1056/NEJMoa1602615. N Engl J Med. 2017. PMID: 28121498 Free article. Clinical Trial.
[Infectious endocarditis].
Camou F, Dijos M. Camou F, et al. Rev Prat. 2023 Jan;73(1):93-101. Rev Prat. 2023. PMID: 36820466 French. No abstract available.
Reply to López-Cortés et al.
Leroy AG, Corvec S, Danneels P, Dubée V, Kempf M, Boucher D, Issa N, Peuchant O, Camou F, Boutoille D, Lecomte R. Leroy AG, et al. Among authors: camou f. Clin Infect Dis. 2021 Jan 27;72(2):361-362. doi: 10.1093/cid/ciaa517. Clin Infect Dis. 2021. PMID: 33501948 No abstract available.
Epidemiology and Clinical Impact of Respiratory Coinfections at Diagnosis of Pneumocystis jirovecii Pneumonia.
Lécuyer R, Issa N, Tessoulin B, Lavergne RA, Morio F, Gabriel F, Canet E, Bressollette-Bodin C, Guillouzouic A, Boutoille D, Raffi F, Lecomte R, Le Turnier P, Deschanvres C, Camou F, Gaborit BJ; PRONOCYSTIS Study Group. Lécuyer R, et al. Among authors: camou f. J Infect Dis. 2022 Mar 2;225(5):868-880. doi: 10.1093/infdis/jiab460. J Infect Dis. 2022. PMID: 34604908
Reply to Pericàs et al.
Lecomte R, Issa N, Camou F, Boutoille D. Lecomte R, et al. Among authors: camou f. Clin Infect Dis. 2020 Dec 31;71(11):3011-3012. doi: 10.1093/cid/ciaa264. Clin Infect Dis. 2020. PMID: 32170327 No abstract available.
[Infective endocarditis].
Camou F, Dijos M. Camou F, et al. Rev Prat. 2014 Oct;64(8):1153-61. Rev Prat. 2014. PMID: 25510149 French. No abstract available.
Avdoralimab (Anti-C5aR1 mAb) Versus Placebo in Patients With Severe COVID-19: Results From a Randomized Controlled Trial (FOR COVID Elimination [FORCE]).
Carvelli J, Meziani F, Dellamonica J, Cordier PY, Allardet-Servent J, Fraisse M, Velly L, Barbar SD, Lehingue S, Guervilly C, Desgrouas M, Camou F, Piperoglou C, Vely F, Demaria O, Karakunnel J, Fares J, Batista L, Rotolo F, Viotti J, Boyer-Chammard A, Lacombe K, Le Dault E, Carles M, Schleinitz N, Vivier E; FOR COVID Elimination (FORCE) Study Group. Carvelli J, et al. Among authors: camou f. Crit Care Med. 2022 Dec 1;50(12):1788-1798. doi: 10.1097/CCM.0000000000005683. Epub 2022 Oct 10. Crit Care Med. 2022. PMID: 36218354 Free PMC article. Clinical Trial.
61 results